U.S. markets open in 3 hours 14 minutes
  • S&P Futures

    +13.00 (+0.34%)
  • Dow Futures

    +13.00 (+0.04%)
  • Nasdaq Futures

    +126.50 (+0.95%)
  • Russell 2000 Futures

    -2.90 (-0.13%)
  • Crude Oil

    +0.52 (+0.99%)
  • Gold

    +8.00 (+0.43%)
  • Silver

    +0.24 (+0.95%)

    -0.0016 (-0.13%)
  • 10-Yr Bond

    0.0000 (0.00%)
  • Vix

    +1.06 (+4.97%)

    +0.0010 (+0.08%)

    +0.0580 (+0.06%)

    -313.97 (-0.94%)
  • CMC Crypto 200

    -5.21 (-0.77%)
  • FTSE 100

    -23.11 (-0.35%)
  • Nikkei 225

    +190.84 (+0.67%)

These 4 Tech Stocks Could Set February Highs

CORAL GABLES, FL / ACCESSWIRE / February 4, 2019 / The future of the tech stock market will depend on two key factors: tech experts must continue to work to design and manufacture top-of-the-line products meant to elevate the human experience, and consumers must feel like these new pieces of tech will actually serve a significant purpose in their lives. It's not a matter of coming up with a nuanced approach to a common problem people face, but more so that the solution is something people can actually get behind. If these two prerequisites are met by companies in the tech industry, it may very well catalyze potential investor opportunities in the near future. ParcelPal Technology Inc (PTNYF) (PKG), Maxwell Technologies Inc (MXWL), Top Image Systems Ltd (TISA), and Celldex Therapeutics Inc (CLDX) represent four companies determined to utilize advanced technological solutions to improve the quality of life for consumers on a global scale.

ParcelPal Technology Inc (PTNYF) (PKG), along with other companies in the space, is taking advantage of the fact that, as new technologies have been developed to meet the growing challenges in life, so too has the willingness of consumers to be persuadable, in terms of considering products they otherwise might not consider. ParcelPal utilizes technology-driven logistics to connect consumers with the goods they love, including allowing customers to place orders for cannabis products. Customers can shop at partner businesses and, through the ParcelPal platform, receive their purchased goods within an hour.

ParcelPal Technology Inc (PTNYF) (PKG) has received significant notoriety from both consumers, as well as investors in the tech sector, due to its business model designed around easing access for consumers wishing to order, and have delivered, products they use in their everyday lives.

ParcelPal Technology Inc (PTNYF) (PKG) announced towards the end of last month that the Company had formed a partnership with MADD Canada to aid in the continuous fight to prevent impaired driving. According to the announcement, MADD Canada has endorsed ParcelPal as their official delivery service in Canada. As part of the ParcelPal's national rollout campaign, advertising forParcelPal's service will be seen across the country in various educational forms. Together, MADD Canada and ParcelPal will launch a national awareness campaign focused on educating Canadians on the dangers of impaired driving and the options they have for getting items they want or need without leaving the party.

In a press release regarding the announcement, Kelly Abbott, Presidentand CEO of ParcelPal Technology Inc (PTNYF) (PKG), explained that "asParcelPal dives deeper into cannabis and alcohol delivery, we are very aware of the inherent risks associated with consumption. We take every precaution to ensure the product is not only delivered safely but will be consumed responsibly as well. Our driver training programs and our technology are designed to ensure they do not deliver to a highly intoxicated or underage person."

For More Information On ParcelPal Technology Inc, Click Here

Maxwell Technologies Inc (MXWL), a leading developer and manufacturer of energy solutions, today announced that it has entered into a definitive agreement to be acquired by Tesla, Inc. Per the agreement, Tesla will commence an all-stock exchange offer for all the issued and outstanding shares of the Company, after which the Company will be merged with a Tesla subsidiary and become a wholly owned subsidiary of Tesla.

Dr. Franz Fink, President, and CEO of Maxwell, commented, "we are very excited with today's announcement that Tesla has agreed to acquire Maxwell. Tesla is a well-respected and world-class innovator that shares a common goal of building a more sustainable future. We believe this transaction is in the best interests of Maxwell stockholders and offers investors the opportunity to participate in Tesla's mission of accelerating the advent of sustainable transport and energy."

For More Information On Maxwell Technologies Inc, Click Here

Top Image Systems Ltd (TISA), a global innovator of on-premise and cloud-based applications that optimize content-driven businesses, saw its shares jump 54.61% to $0.82 per share following today's announcement that the Company has entered into a definitive agreement to be acquired by Kofax.

Following the acquisition announcement, Brendan Reidy, CEO of TIS, said, "we're excited by the opportunity to join forces with Kofax. Together we'll be able to provide a broader and deeper range of offerings to our customers while leveraging the strength and stability that comes with being part of a larger global organization."

For More Information on Top Image Systems Ltd, Click Here

Celldex Therapeutics Inc (CLDX) saw impressive gains in the market on Monday, with shares up 20.62%, trading at $0.69 per share. The Company announced back in November 2018 that it had completed a Phase 1 dose-escalation study of CDX-1140, a fully human agonist anti-CD40 antibody.

In a press release regarding the data announcement, Tibor Keler, Chief Scientific Officer of Celldex, said, "We have completed four of the potential eight monotherapy dose levels and, to date, CDX-1140 has been well tolerated. Importantly, we are observing dose-dependent biological effects consistent with CD40-mediated immune cell activity. Based on these positive findings, we have expanded development of the program and recently initiated a combination cohort with CDX-301, our dendritic cell growth factor, to increase the number of dendritic cells which are critical to initiating antitumor immunity and a key target for CDX-1140.

For More Information On Celldex Therapeutics Inc, Click Here

What Is Stock Price (StockPrice.com)?

Stock Price is defined as the price of a single share of a number of saleable stocks of a public company. A stock price is the highest amount an investor or trader is willing to pay for the stock, or the lowest amount that it can be bought for.

StockPrice.com was created for everyone that wants the latest stock quotes, stock charts, company news, and the best financial content.

At Stock Price (StockPrice.com), you get free stock quotes, up-to-date news, international market data, social interaction and the best financial content that will help you manage your financial life.

Legal Disclaimer

Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. JSG Communications, LLC which owns www.StockPrice.com is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release.

JSG Communications, LLC, which owns www.StockPrice.com, may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. JSG Communications, LLC, which owns www.StockPrice.com, may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two.

An Affiliate of JSG Communications, MIDAM VENTURES LLC has been compensated $75,000 per month for 3 months by ParcelPal Technology, Inc. for a period beginning September 1, 2018 and ending February 1, 2019 to publicly disseminate information about (PTNYF/PKG). We may buy or sell additional shares of (PTNYF/PKG) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. We own zero shares.

Please click here for full disclaimer.

Contact Information:


SOURCE: StockPrice.com

View source version on accesswire.com: